Search

Now showing items 1-5 of 5

Phase I study on the safety and preliminary efficacy of allogeneic mesenchymal stem cells in hypoxic-ischemic encephalopathy

Kabatas, Serdar; Civelek, Erdinç; Kaplan, Necati; Savrunlu, Eyüp Can; Sezen, Gülseli Berivan; Chasan, Mourat; Can, Halil; Genç, Ali; Akyuva, Yener; Boyalı, Osman; Diren, Furkan; Karaoz, Erdal (Baishideng Publishing Group Co, 2021)

BACKGROUND Hypoxic-ischemic encephalopathy (HIE) is a leading cause of morbidity and mortality in the adult as well as in the neonate, with limited options for treatment and significant dysfunctionality. AIM To investigate ...

Functional recovery after wharton’s jelly–derived mesenchymal stem cell administration in a patient with traumatic spinal cord injury: a pilot study

Kabatas, Serdar; Civelek, Erdinc; Savrunlu, Eyup Can; Kaplan, Necati; Cetin, Ercan; Diren, Furkan; Boyali, Osman; Guven, Goksel; Karaoz, Erdal (Gelenos, 2021)

The use of stem cells in the treatment of traumatic spinal cord injury (SCI) in recent years has provided promising results. Different sources of cells for transplantation have been used, including mesenchymal stem cells ...

Feasibility of allogeneic mesenchymal stem cells in pediatric hypoxic-ischemic encephalopathy: phase I study

Kabatas, Serdar; Civelek, Erdinç; Savrunlu, Eyüp Can; Kaplan, Necati; Boyalı, Osman; Diren, Furkan; Can, Halil; Genç, Ali; Akkoç, Tunç; Karaoz, Erdal (Baishideng Publishing Group Co, 2021)

Background Hypoxic-ischemic encephalopathy (HIE) is one of the leading causes of death and long-term neurological impairment in the pediatric population. Despite a limited number of treatments to cure HIE, stem cell therapies ...

Wharton's jelly-derived mesenchymal stem cell transplantation in a patient with hypoxic-ischemic encephalopathy: a pilot study

Kabatas, Serdar; Civelek, Erdinc; Inci, Cigdem; Yalcinkaya, Ebru Yilmaz; Gunel, Guelsen; Kir, Guelay; Albayrak, Esra; Ozturk, Erek; Adas, Goekhan; Karaoz, Erdal (Sage Publications Inc, 2018)

Wharton's jelly-derived mesenchymal stem cells (WJ-MSCs) have been introduced as a possible therapy in hypoxic-ischemic encephalopathy (HIE). We report a 16-year-old boy who was treated with WJ-MSCs in the course of HIE ...

Functional recovery after wharton's jelly-derived mesenchymal stem cell administration in a patient with traumatic brain injury: a pilot study

Kabatas, Serdar; Civelek, Erdinc; Sezen, Gulseli Berivan; Kaplan, Necati; Savrunlu, Eyup Can; Cetin, Ercan; Diren, Furkan; Karaoz, Erdal (TURKISH NEUROSURGICAL SOC, 2020)

AIM: To introduce a traumatic brain injury (TBI) patient who underwent stem cell transplantation (SCT) in order to minimize the remaining injury deficiencies. MATERIAL and METHODS: This study included a 29 years old ...